Ivor Royston Insider Profile

4 Followers
Ivor Royston, Director at Biocept, holds 833.12K shares in Viracta Therapeutics (Ticker: VIRX), holds 34.88K shares in Biocept (Ticker: BIOCQ), holds ― shares in Syndax Pharmaceuticals (Ticker: SNDX).
tipranks
Ivor Royston

Ivor Royston
Biocept (BIOCQ)
Director

Ranked #86,579 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-44.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$154K
97.17%
2.83%
0.00%
A breakdown of Ivor Royston's holdings

Insider Roles

Viracta Therapeutics
(VIRX)
Director
Biocept
(BIOCQ)
Director
Syndax Pharmaceuticals
(SNDX)
Director
Roles that Ivor Royston holds in companies

Most Profitable Insider Trade

Stock:
Biocept
(BIOCQ)
Rating:Informative Buy
Date:Feb 17, 2015 - Feb 17, 2016
Return:-0.70%
The most profitable trade made by Ivor Royston

Ivor Royston's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Biocept
Mar 29, 2017
Director
Informative Buy
49.64K
$4.36K
Syndax Pharmaceuticals
Mar 22, 2017
Director
Uninformative Sell
1.72M
Viracta Therapeutics
Sep 12, 2024
Director
Uninformative Buy
7.09K
$149.96K
List of latest transactions for each holding click on a transaction to see Ivor Royston's performance on stock

Ivor Royston insider profile FAQ

What is the percentage of profitable transactions made by Ivor Royston?
The percentage of profitable transactions made by Ivor Royston is 0%.
    What is the average return per transaction made by Ivor Royston?
    The average return per transaction made by Ivor Royston is -44.80%.
      What stocks does Ivor Royston hold?
      Ivor Royston holds: BIOCQ, SNDX, VIRX stocks.
        What was Ivor Royston’s latest transaction?
        Ivor Royston latest transaction was an Uninformative Buy of $7.09K.
          What was Ivor Royston's most profitable transaction?
          Ivor Royston’s most profitable transaction was an Informative Buy of BIOCQ stock on February 17, 2015. The return on the trade was -0.70%.
            What is Ivor Royston's role in Biocept?
            Ivor Royston's role in Biocept is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.